# Beyond the Rash: Cutaneous Peripheral T-Cell Lymphoma as a Diagnostic Pitfall in Primary Care

**Authors:** Jared Hensley, Aura Calderon, Blake C Martin, Cristina Kochi, Andres R Suarez Parraga

PMC · DOI: 10.7759/cureus.102378 · Cureus · 2026-01-27

## TL;DR

This case highlights how a skin rash from T-cell lymphoma can be mistaken for other conditions, leading to delayed diagnosis and the need for early specialist involvement.

## Contribution

The paper presents a clinical case emphasizing the diagnostic challenges of cutaneous T-cell lymphoma in primary care settings.

## Key findings

- A patient with known T-cell lymphoma presented with a rash resembling common dermatologic conditions.
- Early hematology consultation improved diagnostic accuracy and management planning.
- The case highlights the importance of considering lymphoma in rashes with lymphadenopathy or rapid progression.

## Abstract

Cutaneous manifestations of T-cell lymphomas may resemble common dermatologic or infectious conditions, increasing the risk of delayed recognition. We report a 78-year-old woman with known peripheral T-cell lymphoma (PTCL) who presented with a rapidly progressive, diffuse erythematous rash accompanied by cervical lymphadenopathy. Initial evaluation prioritized more common etiologies; however, inpatient medicine broadened the differential diagnosis, prompting early hematology and oncology consultation. Contrast-enhanced CT of the neck demonstrated multiple enlarged, partially necrotic left cervical lymph nodes consistent with disease progression. After multidisciplinary discussions and consideration of prognosis, the patient elected palliative-focused management with oncology follow-up. This case underscores the importance of emergency and primary care clinicians to include cutaneous lymphoma in the differential diagnosis of new diffuse rashes in patients with known or suspected hematologic malignancy, particularly when accompanied by lymphadenopathy or rapid progression.

## Linked entities

- **Diseases:** peripheral T-cell lymphoma (MONDO:0000430), hematologic malignancy (MONDO:0002334)

## Full-text entities

- **Genes:** ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}
- **Diseases:** erythroderma (MESH:D003873), oncologic disease (MESH:D000072716), necrosis (MESH:D009336), pyuria (MESH:D011776), lymphoproliferative disorders (MESH:D008232), heart failure (MESH:D006333), Mycosis fungoides (MESH:D009182), type 2 diabetes mellitus (MESH:D003924), peripheral arterial disease (MESH:D058729), cutaneous lymphoma (MESH:D008223), extranodal non-Hodgkin lymphomas (MESH:D008228), Hypersensitivity (MESH:D004342), Drug eruption (MESH:D003875), leukocytosis (MESH:D007964), urinary tract infection (MESH:D014552), T-cell lymphomas (MESH:D016399), glandular (MESH:D009375), anemia (MESH:D000740), hematologic disease (MESH:D006402), eczema (MESH:D004485), hematologic malignancy (MESH:D019337), fever (MESH:D005334), Psoriasis (MESH:D011565), Sezary syndrome (MESH:D012751), cervical lymphadenopathy (MESH:D002575), oral or ocular mucosal lesions (MESH:D009059), cardiac arrhythmias (MESH:D001145), urticaria (MESH:D014581), obesity (MESH:D009765), lymphadenopathy (MESH:D008206), pruritic (MESH:C535817), diffuse rashes (MESH:D005076), hypoalbuminemia (MESH:D034141), chest pain (MESH:D002637), lymphopenia (MESH:D008231), adenopathy (MESH:D000072281), malignancy (MESH:D009369), dyspnea (MESH:D004417), Cutaneous Peripheral T-Cell Lymphoma (MESH:D016411), bacteriuria (MESH:D001437), eosinophilia (MESH:D004802), hyperglycemia (MESH:D006943), cutaneous disease (MESH:D004194), inflammation (MESH:D007249), hepatic dysfunction (MESH:D008107), inflammatory dermatoses (MESH:D012871), CTCL (MESH:D016410)
- **Chemicals:** prednisone (MESH:D011241), ceftriaxone (MESH:D002443), nitrites (MESH:D009573), dexamethasone (MESH:D003907), loratadine (MESH:D017336), bilirubin (MESH:D001663), diphenhydramine (MESH:D004155)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12937029/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12937029/full.md

## References

9 references — full list in the complete paper: https://tomesphere.com/paper/PMC12937029/full.md

---
Source: https://tomesphere.com/paper/PMC12937029